Detalhe da pesquisa
1.
Worldwide disparities in access to treatment and investigations for nephropathic cystinosis: a 2023 perspective.
Pediatr Nephrol
; 39(4): 1113-1123, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37978055
2.
Addressing the psychosocial aspects of transition to adult care in patients with cystinosis.
Pediatr Nephrol
; 2024 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38517536
3.
Clinical and genetic characteristics of Dent's disease type 1 in Europe.
Nephrol Dial Transplant
; 38(6): 1497-1507, 2023 05 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36441012
4.
X-linked hypophosphatemia, obesity and arterial hypertension: data from the XLH21 study.
Pediatr Nephrol
; 38(3): 697-704, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35758999
5.
Diagnosis and management of Bartter syndrome: executive summary of the consensus and recommendations from the European Rare Kidney Disease Reference Network Working Group for Tubular Disorders.
Kidney Int
; 99(2): 324-335, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33509356
6.
Cystinuria: clinical practice recommendation.
Kidney Int
; 99(1): 48-58, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32918941
7.
An international cohort study spanning five decades assessed outcomes of nephropathic cystinosis.
Kidney Int
; 100(5): 1112-1123, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34237326
8.
Safety, efficacy, and acceptability of ADV7103 during 24 months of treatment: an open-label study in pediatric and adult patients with distal renal tubular acidosis.
Pediatr Nephrol
; 36(7): 1765-1774, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33635379
9.
Adherence to cysteamine in nephropathic cystinosis: A unique electronic monitoring experience for a better understanding. A prospective cohort study: CrYSTobs.
Pediatr Nephrol
; 36(3): 581-589, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32901297
10.
Correction to: Efficacy and safety of an innovative prolonged-release combination drug in patients with distal renal tubular acidosis: an open-label comparative trial versus standard of care treatments.
Pediatr Nephrol
; 36(1): 215, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32989611
11.
Efficacy and safety of an innovative prolonged-release combination drug in patients with distal renal tubular acidosis: an open-label comparative trial versus standard of care treatments.
Pediatr Nephrol
; 36(1): 83-91, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32712761
12.
Composition of urinary stones in children: clinical and metabolic determinants in a French tertiary care center.
Eur J Pediatr
; 180(12): 3555-3563, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34165592
13.
Eplet incompatibility in pediatric renal transplantation.
Pediatr Transplant
; 24(6): e13721, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32388894
14.
Intermittent cholecalciferol supplementation in children and teenagers followed in pediatric nephrology: data from a prospective single-center single-arm open trial.
Eur J Pediatr
; 179(4): 661-669, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31873802
15.
Bone Disease in Nephropathic Cystinosis: Beyond Renal Osteodystrophy.
Int J Mol Sci
; 21(9)2020 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32354056
16.
Fluconazole as a New Therapeutic Tool to Manage Patients With NPTIIc (SLC34A3) Mutation: A Case Report.
Am J Kidney Dis
; 73(6): 886-889, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30765103
17.
Treatment and long-term outcome in primary distal renal tubular acidosis.
Nephrol Dial Transplant
; 34(6): 981-991, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30773598
18.
Minoxidil versus placebo in the treatment of arterial wall hypertrophy in children with Williams Beuren Syndrome: a randomized controlled trial.
BMC Pediatr
; 19(1): 170, 2019 05 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31138170
19.
Hyperphosphatemic tumoral calcinosis caused by FGF23 compound heterozygous mutations: what are the therapeutic options for a better control of phosphatemia?
Pediatr Nephrol
; 33(7): 1263-1267, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29594503
20.
Teenagers and young adults with nephropathic cystinosis display significant bone disease and cortical impairment.
Pediatr Nephrol
; 33(7): 1165-1172, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29435659